Skip to main content

Table 3 Visit schedule

From: Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial

 

Screening

Treatment

EOS

Visit number

0

1

2

3

Day

-5 to -1

1

7 to 11(EOT)

85 to 99

Informed consent

X

   

Check in/exclusion criteria

X

   

Randomization

 

X

  

Demographic data

X

   

Medical history

X

   

Charlson score

X

   

Pitt bacteremia score

X

   

Current medication

X

X

X

X

Infective focus

X

   

Clinical data

    

Physical examination

X

X

  

Vital signs

X

X

  

Outcome assessment

    

SAB-related complications

  

X

X

Length of stay (in days)

  

X

X

90-day mortality

   

X

Safety

    

Adverse events

 

X

X

X

Clostridium difficile-associated diarrhea

 

X

X

X

Complications of iv therapy

 

X

X

X

Laboratory data

    

The following routine laboratory results are documented once from day −3 to 1, if available: Hemoglobin, red and white blood cell count, platelet count, serum sodium, serum potassium, serum creatinine, liver function tests, creatine phosphokinase, C-reactive protein, blood culture

X

   

Pregnancy test in premenopausal women

X